Cancer Res Treat.
2001 Jun;33(3):229-235.
Expression of Cyclin D1 and CDK4 in DMBA-Induced Rat Ovarian Cancer
- Affiliations
-
- 1Department of Pathology, College of Medicine, Dongguk University, Gyeongju, Korea.
Abstract
-
PURPOSE: Ovarian cancer is a common gynecologic malignancy and the leading cause of death in women. It is typically
not diagnosed until it has reached the advanced stages. We performed this study to investigate the roles of the proteins
related to the G1 cell cycle in ovarian carcinogenesis.
MATERIALS AND METHODS
Immunohistochemistry and Western blot were used to analyse the expression of cyclin Dl
and CDK4 in 7, 12-dimethylbenzanthracene- induced ovarian cancer in rats.
RESULTS
The Cyclin D1 and CDK4 labelling index was significantly higher in the ovarian cancers than in the normal
ovarian surface epithelium of rats. There was no difference among the cancer types. In Western blot
analyses, the expression of cyclin Dl and CDK4 in the ovarian cancers was higher than that in the normal ovarian
surface epithelium. A positive correlation was observed between the expressions of the CDK4 and Cyclin D1.
CONCLUSION
The upregulation of cyclin Dl and CDK4 that occurs in DMBA-induced rat ovarian carcinogenesis is likely
to be associated with tumor progression. Further studies are needed to investigate the role and function of cyclin
Dl and CDK4 in human ovarian cancer.